Cargando…

Beta cell antigens in type 1 diabetes: triggers in pathogenesis and therapeutic targets

Mostrar otras versiones (1)

Recognition of pancreatic beta cell antigens by autoreactive T lymphocytes plays a central role in the pathogenesis of insulin-dependent type 1 diabetes. Recent results suggest that non-conventional antigenic epitope processing and presentation may contribute to triggering and maintaining autoreacti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moser, Anna, Hsu, Hsiang-Ting, van Endert, Peter
Formato:	Texto
Lenguaje:	English
Publicado:	Faculty of 1000 Ltd 2010
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2981181/ https://www.ncbi.nlm.nih.gov/pubmed/21173836 http://dx.doi.org/10.3410/B2-75

Ejemplares similares

Beta cell antigens in type 1 diabetes: triggers in pathogenesis and therapeutic targets
por: Mauvais, François-Xavier, et al.
Publicado: (2016)

No Major Role for Insulin-Degrading Enzyme in Antigen Presentation by MHC Molecules
por: Culina, Slobodan, et al.
Publicado: (2014)

Editorial: Insights in antigen presenting cell biology: 2021
por: van Endert, Peter
Publicado: (2022)

Editorial: Insights in antigen presenting cell biology: 2022
por: van Endert, Peter
Publicado: (2023)

Therapeutic Interventions Targeting Beta Amyloid Pathogenesis in an Aging Dog Model
por: Martin, Sarah B, et al.
Publicado: (2011)

The Role of Insulin-Regulated Aminopeptidase in MHC Class I Antigen Presentation
por: Saveanu, Loredana, et al.
Publicado: (2012)

IL-20 in Acute Kidney Injury: Role in Pathogenesis and Potential as a Therapeutic Target
por: Lin, Tian-Yu, et al.
Publicado: (2020)

The Impact of Pancreatic Beta Cell Heterogeneity on Type 1 Diabetes Pathogenesis
por: Benninger, Richard K. P., et al.
Publicado: (2018)

Endocytic Recycling of MHC Class I Molecules in Non-professional Antigen Presenting and Dendritic Cells
por: Montealegre, Sebastian, et al.
Publicado: (2019)

The miRNA Profile of Human Pancreatic Islets and Beta-Cells and Relationship to Type 2 Diabetes Pathogenesis
por: van de Bunt, Martijn, et al.
Publicado: (2013)

Confirmation and Identification of Biomarkers Implicating Environmental Triggers in the Pathogenesis of Type 1 Diabetes
por: Harms, Robert Z., et al.
Publicado: (2020)

Hepatitis B x antigen (HBx) is an important therapeutic target in the pathogenesis of hepatocellular carcinoma
por: Medhat, Arvin, et al.
Publicado: (2021)

Partners in Crime: Beta-Cells and Autoimmune Responses Complicit in Type 1 Diabetes Pathogenesis
por: Toren, Eliana, et al.
Publicado: (2021)

Pneumolysin: Pathogenesis and Therapeutic Target
por: Nishimoto, Andrew T., et al.
Publicado: (2020)

New Insights into Diabetic Kidney Disease: The Potential Pathogenesis and Therapeutic Targets
por: Liu, Wei Jing, et al.
Publicado: (2017)

Autoimmune Hepatitis—Immunologically Triggered Liver Pathogenesis—Diagnostic and Therapeutic Strategies
por: Sucher, Elisabeth, et al.
Publicado: (2019)

The Pathogenesis of Sepsis and Potential Therapeutic Targets
por: Huang, Min, et al.
Publicado: (2019)

Mycobacterium tuberculosis: Pathogenesis and therapeutic targets
por: Yang, Jiaxing, et al.
Publicado: (2023)

The pathogenesis and potential therapeutic targets in sepsis
por: Zhang, Wendan, et al.
Publicado: (2023)

Arginase 2 and Polyamines in Human Pancreatic Beta Cells: Possible Role in the Pathogenesis of Type 2 Diabetes
por: Marselli, Lorella, et al.
Publicado: (2021)

Editorial: Organ Fibrosis: Pathogenesis, Biomarkers and Therapeutic Targets
por: Mutsaers, Henricus A. M., et al.
Publicado: (2021)

Enteroviral infections in the pathogenesis of type 1 diabetes: new insights for therapeutic intervention
por: Richardson, Sarah J, et al.
Publicado: (2018)

Gut microbiota and diabetic kidney diseases: Pathogenesis and therapeutic perspectives
por: Lin, Jia-Ran, et al.
Publicado: (2022)

Tough antigens trigger immunity
por: Van Epps, Heather L.
Publicado: (2006)

The Pathogenesis and Therapeutic Approaches of Diabetic Neuropathy in the Retina
por: Oshitari, Toshiyuki
Publicado: (2021)

Gut microbiota in the pathogenesis and therapeutic approaches of diabetes
por: Crudele, Lucilla, et al.
Publicado: (2023)

Non-antigenic and antigenic interventions in type 1 diabetes
por: Rydén, Anna KE, et al.
Publicado: (2013)

Pathogenesis and New Therapeutic Targets of Ovarian Cancer
por: Shih, Ie-Ming, et al.
Publicado: (2012)

Pathogenesis of Preeclampsia and Therapeutic Approaches Targeting the Placenta
por: Jena, Manoj Kumar, et al.
Publicado: (2020)

Neutrophils in liver diseases: pathogenesis and therapeutic targets
por: Liu, Kai, et al.
Publicado: (2020)

Exosomes in brain diseases: Pathogenesis and therapeutic targets
por: Si, Qingying, et al.
Publicado: (2023)

Obesity and Type 2 Diabetes: Adiposopathy as a Triggering Factor and Therapeutic Options
por: Artasensi, Angelica, et al.
Publicado: (2023)

Novel Antigenic Targets of HPV Therapeutic Vaccines
por: Boilesen, Ditte Rahbæk, et al.
Publicado: (2021)

Antigenic and immunogenic properties of chondrocytes. Implications for chondrocyte therapeutic transplantation and pathogenesis of inflammatory and degenerative joint diseases
por: Osiecka-Iwan, Anna, et al.
Publicado: (2018)

Beware the algorithm
por: van Endert, Peter
Publicado: (2021)

Targeting pancreatic beta cell death in type 2 diabetes by polyphenols
por: García-Aguilar, Ana, et al.
Publicado: (2022)

Oxidative stress in genetically triggered thoracic aortic aneurysm: role in pathogenesis and therapeutic opportunities
por: Portelli, Stefanie S., et al.
Publicado: (2021)

Self-Antigens Targeted by Regulatory T Cells in Type 1 Diabetes
por: Mitchell, Angela M., et al.
Publicado: (2022)

Tandem mass tag-based serum proteomic profiling revealed diabetic foot ulcer pathogenesis and potential therapeutic targets
por: Yu, Xiao-Ting, et al.
Publicado: (2022)

Metals in the pathogenesis of type 2 diabetes
por: Khan, Abdul Rehman, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_6jbrofugi3b6f4tblsr63itgt6